Vikrant Vijay
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 9
-
- Advancements in Transdermal Drug Delivery 4
- Co-authors
- Varsha G. Desai (16 shared papers)James C. Fuscoe (16 shared papers)Carrie L. Moland (14 shared papers)Qiang Shi (2 shared papers)Hong Fang (1 shared paper)Minjun Chen (1 shared paper)Weida Tong (1 shared paper)Zhichao Liu (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Biology of Sex Differences (3 papers)PLoS ONE (3 papers)Journal of Toxicology and Environmental Health (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesSouth KoreaIndia
In The Last Decade
Vikrant Vijay
28 papers receiving 899 citations
Vikrant Vijay's Hit Papers
Peers
Comparison fields: 5 of 109
- Pharmacology 223
- Cardiology and Cardiovascular Medicine 197
- Computational Theory and Mathematics 128
- Cancer Research 79
- Hepatology 41
Countries citing papers authored by Vikrant Vijay
This map shows the geographic impact of Vikrant Vijay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikrant Vijay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikrant Vijay more than expected).
Fields of papers citing papers by Vikrant Vijay
This network shows the impact of papers produced by Vikrant Vijay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikrant Vijay. The network helps show where Vikrant Vijay may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikrant Vijay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA-approved drug labeling for the study of drug-induced liver injury Hit paper breakdown → | 2011 | 333 |
| 2 | 2014 | 85 | |
| 3 | 2015 | 79 | |
| 4 | 2015 | 69 | |
| 5 | 2013 | 48 | |
| 6 | 2016 | 36 | |
| 7 | 2016 | 35 | |
| 8 | 2015 | 26 | |
| 9 | 2016 | 26 | |
| 10 | 2018 | 21 | |
| 11 | 2017 | 21 | |
| 12 | 2020 | 17 | |
| 13 | 2018 | 17 | |
| 14 | 2013 | 16 | |
| 15 | 2007 | 15 | |
| 16 | 2022 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2009 | 10 | |
| 19 | 2015 | 10 | |
| 20 | 2018 | 7 |
About Vikrant Vijay
Vikrant Vijay is a scholar working on Cardiology and Cardiovascular Medicine, Pharmaceutical Science, Dermatology, Cancer Research and Biophysics, having authored 29 papers that have together received 916 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Advancements in Transdermal Drug Delivery (4 papers), Carbon Nanotubes in Composites (4 papers), Cancer Treatment and Pharmacology (3 papers), Contact Dermatitis and Allergies (3 papers), Analytical Chemistry and Chromatography (2 papers), Electron Spin Resonance Studies (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Pharmacology (223 citations), Cardiology and Cardiovascular Medicine (197 citations), Computational Theory and Mathematics (128 citations), Cancer Research (79 citations) and Hepatology (41 citations). Vikrant Vijay has collaborated with scholars based in United States, South Korea and India. Frequent co-authors include Varsha G. Desai, James C. Fuscoe, Carrie L. Moland, Qiang Shi, Hong Fang, Minjun Chen, Weida Tong, Zhichao Liu, Joshua C. Kwekel and Tao Han. Their work appears in journals such as Toxicology and Applied Pharmacology, Biology of Sex Differences, PLoS ONE, Journal of Toxicology and Environmental Health and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.